T. Lawson

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.

R. Moots, K. Chakravarty, B. Griffiths, 2007, Arthritis and rheumatism.

Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.

R. Moots, B. Kirkham, A. Taggart, 2005, Rheumatology.

Signalling through neutrophil Fc gamma RIII, Fc gamma RII, and CD59 is not impaired in active rheumatoid arthritis.

I. Laffafian, B. Morgan, B. Williams, 1996, Annals of the rheumatic diseases.

impaired in active rheumatoid arthritis

I. Laffafian, B. Morgan, B. Williams, 2022 .

Signalling through neutrophil Fc-yRIII, FcyRII, and CD59 is not impaired in active rheumatoid arthritis

I. Laffafian, B. Morgan, B. Williams, 2022 .

Myeloproliferative Disease: An Unusual Cause of Raynaud's Phenomenon and Digital Ischaemia

T. Lawson, Gwenan Huws, C. Beynon, 2016, Case reports in medicine.

C reactive protein may not be reliable as a marker of severe bacterial infection in patients receiving tocilizumab

T. Lawson, S. F. Bari, Afsha Khan, 2013, BMJ Case Reports.